then stirred at 80 ꢂC for 3.5 h. After the reaction 30 ml of water
are added and the solution extracted with DCM. Column puri-
fication with silica gel and petroleum ether/DCM (v/v) 1 : 1 and
later 1 : 2 as eluent gives (10) (0.97 g, 74%) as dark oil. 1H NMR
(500 MHz, d6-acetone): d ¼ 9.68 (s, 1H), 7.40 (dd, J ¼ 8.29, 1.78
Hz, 1H), 7.37 (d, J ¼ 5.08 Hz, 1H), 7.34 (d, J ¼ 3.58 Hz, 1H), 7.13
(dd, J ¼ 8.35, 2.07 Hz, 1H), 7.07 (dd, J ¼ 5.02, 3.66 Hz, 1H), 7.04
(d, J ¼ 1.79 Hz, 1H), 6.95 (d, J ¼ 2.08 Hz, 1H), 6.82 (d, J ¼ 8.30
Hz, 1H), 6.78 (d, J ¼ 8.39 Hz, 1H), 3.65–3.74 (m, 2H), 1.66–1.75
(m, 2H), 1.44–1.51 (m, 2H), 1.27–1.43 (m, 7H), 0.88 ppm (t, J ¼
6.80, 6.80 Hz, 3H).
2H), 1.53–1.59 (m, 2H), 1.37–1.41 (m, 2H), 1.26–1.33 (m, 8H),
0.87 ppm (t, J ¼ 6.89 Hz, 3H); 13C NMR (126 MHz, d6-DMSO):
d ¼ 163.8, 152.5, 146.4, 144.4, 143.7, 141.6, 134.4, 133.1, 131.7,
124.8, 124.3, 123.8, 122.6, 121.6, 116.7, 115.2, 112.4, 112.3, 112.2,
31.2, 28.8, 28.7, 26.0, 24.5, 22.1, 13.9 ppm; ESI-HRMS calcd. for
C28H28N2O3S [M+] 472.1815, found 472.1831.
(E)-2-Cyano-3-(4-(4-(diphenylamino)phenyl)-5-(7-(4-(diphenylamino)-
phenyl)-10-octyl-10H-phenoxazin-3-yl)thiophen-2-yl)acrylic acid
(IB2). Compound (10) (160 mg, 0.2 mmol) and 2-cyanoacetic
acid (60 mg, 0.7 mmol) are dissolved in 20 ml acetonitrile. 4 drops
of piperidine are added and the mixture is then refluxed for 1 h.
After evaporation of the solvent the crude product is purified by
column chromatography with silica gel and DCM/MeOH (20 : 1;
v/v) as eluent to give IB2 (126 mg, 73%) as a deep red powder. 1H
NMR (500 MHz, d6-DMSO): d ¼ 8.42 (s, 1H), 7.97 (s, 1H), 7.49
(d, J ¼ 8.5 Hz, 2H), 7.25–7.31 (m, 8H), 7.28 (d, J ¼ 8.5 Hz, 2H),
7.12 (d, 3.26 Hz, 1H), 6.89–7.09 (m, 18 H), 6.79 (d, J ¼ 8.46 Hz,
1H), 6.74 (d, J ¼ 8.31 Hz, 1H), 6.56 (d, J ¼ 1.86 Hz, 1H), 3.52–
3.55 (m, 2H), 1.53–1.46 (m, 2H), 1.45–1.38 (m, 2H), 1.35–1.29
(m, 8H), 0.88 ppm (t, J ¼ 6.88, 6.88 Hz, 3H); 13C NMR (126
MHz, d6-DMSO): d ¼ 163.5, 147.0, 146.9, 146.2, 144.0, 143.7,
138.0, 133.5, 132.8, 132.6, 130.8, 130.0, 129.5, 128.5, 126.5, 124.8,
124.6, 124.0, 123.4, 123.3, 123.1, 122.8, 121.6, 116.6, 114.7, 112.7,
112.6, 112.1, 31.2, 28.8, 28.7, 26.0, 24.5, 22.1, 13.4 ppm; ESI-
HRMS calcd. for C64H54N4O3S [M+] 958.3911, found 958.3909.
7-(3,5-Dibromothiophen-2-yl)-10-octyl-10H-phenoxazine-3-car-
baldehyde (11). Compound (10) (0.49 g, 1.2 mmol) is dissolved in
5 ml DCM in an ice bath and bromine (0.38 g, 2.4 mmol) dis-
solved in 4 ml DCM is added to the solution over 20 min. The
mixture is stirred at 0 ꢂC for additional 30 min and then removed
from the ice bath to continue stirring for 2.5 h. When the reaction
is finished, 20 ml of dilute sodium hydroxide solution is added
and the solution extracted with DCM. Column purification with
silica gel and DCM as eluent gives (11) (0.52 g, 77.5%) as brown
solid. 1H NMR (500 MHz, d6-acetone): d ¼ 9.60 (s, 1H), 7.28 (dd,
J ¼ 8.27, 1.71 Hz, 1H), 7.03 (s, 1H), 6.98 (dd, J ¼ 8.37, 2.09 Hz,
1H), 6.92 (d, J ¼ 1.73 Hz, 1H), 6.79 (d, J ¼ 2.13 Hz, 1H), 6.66 (d,
J ¼ 8.33 Hz, 1H), 6.61 (d, J ¼ 8.45 Hz, 1H), 3.48–3.53 (m, 2H),
1.55–1.62 (m, 2H), 1.25–1.43 (m, 8H), 0.86 ppm (t, J ¼ 6.85, 6.85
Hz, 3H).
(E)-2-Cyano-3-(4-(2,4-dibutoxyphenyl)-5-(7-(2,4-dibutoxyphenyl)-
10-octyl-10H-phenoxazin-3-yl)thiophen-2-yl)acrylic acid (IB3).
Compound (9) (230 mg, 0.28 mmol) and 2-cyanoacetic acid
(90 mg, 1.1 mmol) are dissolved in 12 ml acetonitrile. 10 drops of
piperidine are added and the mixture is then refluxed for 2.5 h.
After evaporation of the solvent the crude product is purified by
column chromatography with silica gel and DCM/MeOH (20 : 1;
v/v) as eluent to give IB3 (190 mg, 75%) as a deep red powder. 1H
NMR (500 MHz, d6-acetone): d ¼ 8.35 (s, 1H), 7.81 (s, 1H), 7.14
(d, J ¼ 8.40 Hz, 1H), 7.09 (d, J ¼ 8.35 Hz, 1H), 6.96 (dd, J ¼ 8.30,
1.89 Hz, 1H), 6.87 (dd, J ¼ 8.40, 1.96 Hz, 1H), 6.80 (d, J ¼ 1.90
Hz, 1H), 6.49–6.63 (m, 7H), 3.99–3.95 (m, 6H), 3.86 (t, J ¼ 6.49,
6.49 Hz, 2H), 3.57–3.53 (m, 2H), 1.60–1.77 (m, 8H), 1.54–1.39
(m, 10H), 1.24–1.39 (m, 10H), 0.84–0.98 ppm (m, 15H); 13C
NMR (126 MHz, d6-acetone): d ¼ 164.4, 161.6, 160.6, 158.2,
157.8, 149.4, 147.1, 145.5, 144.6, 144.5, 136.2, 134.9, 133.0, 132.7,
132.4, 131.3, 131.1, 127.2, 125.4, 124.8, 122.7, 117.6, 117.2, 117.1,
115.0, 112.3, 112.3, 106.6, 106.5, 101.1, 100.9, 98.7, 68.6, 68.4,
68.3, 44.3, 32.6, 32.2, 32.1, 31.8, 27.4, 23.4, 20.0, 19.9, 19.8, 14.4,
14.2 ppm; ESI-HRMS calcd. for C56H68N2NaO7S [M + Na+]
935.4639, found 935.4597.
7-(3,5-Bis(4-(diphenylamino)phenyl)thiophen-2-yl)-10-octyl-10H-
phenoxazine-3-carbaldehyde (12). The compound (11) (250 mg,
0.4 mmol), (4-(diphenylamino)phenyl)boronic acid (500 mg,
1.8 mmol), potassium carbonate (300 mg, 2.2 mmol) and [1,10-bis
(diphenylphosphino)ferrocene]-dichloropalladium(II) (80 mg,
0.1 mmol) are placed in two sealable flasks and dissolved in 6 ml
of toluene/DCM (1 : 1; v/v) each flask. The mixtures are then
stirred at 80 ꢂC for 3 h. After the reaction 30 ml of water are
added and the solution is extracted with DCM. Column purifi-
cation with silica gel and petroleum ether/DCM (v/v) 1 : 1 and
later 1 : 2 as eluent gives (12) (290 mg, 73%) as a yellow solid. 1H
NMR (500 MHz, d6-acetone): d ¼ 9.70 (s, 1H), 7.62 (d, J ¼ 8.63
Hz, 2H), 7.40–7.43 (m, 2H), 7.27–7.35 (m, 10H), 7.08–7.12 (m,
10H), 7.00–7.06 (m, 7H), 6.91 (dd, J ¼ 8.33, 2.04 Hz, 1H), 6.84
(d, J ¼ 8.33 Hz, 1H), 6.75 (d, J ¼ 8.42 Hz, 1H), 6.55 (d, J ¼ 2.03
Hz, 1H), 3.66–3.70 (m, 2H), 1.67–1.74 (m, 2H), 1.45–1.52 (m,
2H), 1.29–1.44 (m, 8H), 0.87 ppm (t, J ¼ 6.84, 6.84 Hz, 3H).
(E)-2-Cyano-3-(5-(10-octyl-10H-phenoxazin-3-yl)thiophen-2-yl)
acrylic acid (IB1). Compound (6) (62 mg, 0.15 mmol) and
2-cyanoacetic acid (50 mg, 0.6 mmol) are dissolved in 10 ml
acetonitrile. 4 drops of piperidine are added and the mixture is
then refluxed for 2 h. After evaporation of the solvent the crude
product is purified by column chromatography with silica gel and
DCM as eluent at first, then change to DCM/ethyl acetate (v/v)
5 : 1 and finally 10 : 1. To get rid of remained impurities the dye
is recrystallized with 5 ml acetone and 5 ml pentane to finally give
IB1 (40 mg, 56%) as a deep red powder. 1H NMR (500 MHz, d6-
DMSO): d ¼ 8.44 (s, 1H), 7.96 (d, J ¼ 4.03 Hz, 1H), 7.63 (d, J ¼
4.06 Hz, 1H), 7.25 (dd, J ¼ 8.38, 2.13 Hz, 1H), 7.09 (d, J ¼ 2.14
Hz, 1H), 6.85–6.88 (m, 1H), 6.76–6.97 (m, 4H), 3.58–3.61 (m,
(E)-3-(7-(3,5-Bis(4-(diphenylamino)phenyl)thiophen-2-yl)-10-
octyl-10H-phenoxazin-3-yl)-2-cyanoacrylic acid (IB4). The
compound (13) (220 g, 2.4 mmol) and 2-cyanoacetic acid (80 mg,
1.0 mmol) are dissolved in 15 ml acetonitrile. 10 Drops of
piperidine are added and the mixture is then refluxed for 2.5 h.
After evaporation of the solvent the crude product is purified by
column chromatography with silica gel and DCM/MeOH (10 : 1;
1
v/v) as eluent to give IB4 (113 mg, 49%) as a dark powder. H
NMR (500 MHz, d6-acetone): d ¼ 7.99 (s, 1H), 7.58 (d, J ¼ 8.65
Hz, 2H), 7.53 (dd, J ¼ 8.57, 2.01 Hz, 1H), 7.46 (s, 1H), 7.37 (d,
12464 | J. Mater. Chem., 2011, 21, 12462–12472
This journal is ª The Royal Society of Chemistry 2011